Seeds of Change Organic Quinoa, Brown & Red Rice
TINA.org reader flags main ingredient fail.
StemGenex
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)
The Latest
Dave ExtraCash Advance
What you should know about this fast cash offer.
Can You Tell Me How to Pay at Sesame Place?
Theme park fails to adequately disclose that it’s a “cashless” operation.
Did Timothée Chalamet Just Take a Dig at Deceptive Marketing?
Why I’m a fan of this Adidas World Cup ad.
‘Bet Now’: How Wagering Apps’ Push Notification Ads Bombard Consumers
TINA.org joins petition urging FTC to require consent and opt-out for gambling marketing.